Representativeness of randomized clinical trial cohorts in end-stage kidney disease
<br><strong>Importance: </strong>Systematic differences between patients included in randomized clinical trials (RCTs) and the general patient population may influence the generalizability of RCT findings. Comprehensive national registries of patients with end-stage kidney disease...
Main Authors: | Smyth, B, Haber, A, Trongtrakul, K, Hawley, C, Perkovic, V, Woodward, M, Jardine, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Medical Association
2019
|
Similar Items
-
Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review
by: Smyth, B, et al.
Published: (2019) -
Renal end points in clinical trials of kidney disease
by: Weldegiorgis, M, et al.
Published: (2015) -
Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial
by: Ninomiya, T, et al.
Published: (2008) -
Oxygenated end-hypothermic machine perfusion in expanded criteria donor kidney transplant: a randomized clinical trial
by: Husen, P, et al.
Published: (2021) -
Cardiac evaluation for end-stage kidney disease patients on the transplant waitlist: a single-center cohort study
by: Vijayan, Swati, et al.
Published: (2023)